BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 17125903)

  • 1. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre MR
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):215-23. PubMed ID: 17125903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal status: a possible predictive factor for recurrence in women with cancer of the uterine cervix without pelvic lymph node metastasis.
    Fregnani JH; Latorre MR; Novik PR; Lopes A; Soares FA
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):204-9. PubMed ID: 19450920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma.
    Eifel PJ; Burke TW; Morris M; Smith TL
    Gynecol Oncol; 1995 Oct; 59(1):38-44. PubMed ID: 7557613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of keratinization in squamous cell cancer of uterine cervix: a population based study.
    Kumar S; Shah JP; Bryant CS; Imudia AN; Ali-Fehmi R; Malone JM; Morris RT
    Arch Gynecol Obstet; 2009 Jul; 280(1):25-32. PubMed ID: 19043726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Lee CC; Tang SG; Hsueh S
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):492-9. PubMed ID: 15925454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix.
    Huang EY; Wang CJ; Chen HC; Fang FM; Huang YJ; Wang CY; Hsu HC
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):834-42. PubMed ID: 18439764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix.
    Chargui R; Damak T; Khomsi F; Ben Hassouna J; Chaieb W; Hechiche M; Gamoudi A; Boussen H; Benna F; Rahal K
    Am J Obstet Gynecol; 2006 Jan; 194(1):43-8. PubMed ID: 16389008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.